These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37175811)

  • 1. Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer.
    Di Matteo A; Belloni E; Pradella D; Chiaravalli AM; Pini GM; Bugatti M; Alfieri R; Barzan C; Franganillo Tena E; Bione S; Terenzani E; Sessa F; Wyatt CDR; Vermi W; Ghigna C
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculature.
    Gallo S; Arcidiacono MV; Tisato V; Piva R; Penolazzi L; Bosi C; Feo CV; Gafà R; Secchiero P
    Onco Targets Ther; 2018; 11():6049-6056. PubMed ID: 30275709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alternative splicing factor Nova2 regulates vascular development and lumen formation.
    Giampietro C; Deflorian G; Gallo S; Di Matteo A; Pradella D; Bonomi S; Belloni E; Nyqvist D; Quaranta V; Confalonieri S; Bertalot G; Orsenigo F; Pisati F; Ferrero E; Biamonti G; Fredrickx E; Taveggia C; Wyatt CD; Irimia M; Di Fiore PP; Blencowe BJ; Dejana E; Ghigna C
    Nat Commun; 2015 Oct; 6():8479. PubMed ID: 26446569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing.
    Angiolini F; Belloni E; Giordano M; Campioni M; Forneris F; Paronetto MP; Lupia M; Brandas C; Pradella D; Di Matteo A; Giampietro C; Jodice G; Luise C; Bertalot G; Freddi S; Malinverno M; Irimia M; Moulton JD; Summerton J; Chiapparino A; Ghilardi C; Giavazzi R; Nyqvist D; Gabellini D; Dejana E; Cavallaro U; Ghigna C
    Elife; 2019 Mar; 8():. PubMed ID: 30829570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial Cells.
    Belloni E; Di Matteo A; Pradella D; Vacca M; Wyatt CDR; Alfieri R; Maffia A; Sabbioneda S; Ghigna C
    Cells; 2019 Nov; 8(12):. PubMed ID: 31771184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis.
    Pradella D; Deflorian G; Pezzotta A; Di Matteo A; Belloni E; Campolungo D; Paradisi A; Bugatti M; Vermi W; Campioni M; Chiapparino A; Scietti L; Forneris F; Giampietro C; Volf N; Rehman M; Zacchigna S; Paronetto MP; Pistocchi A; Eichmann A; Mehlen P; Ghigna C
    Nat Commun; 2021 Aug; 12(1):4872. PubMed ID: 34381052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Splicing by NOVA Factors: From Gene Expression to Cell Physiology and Pathology.
    Meldolesi J
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuro-oncological Ventral Antigen 2 Regulates Splicing of Vascular Endothelial Growth Factor Receptor 1 and Is Required for Endothelial Function.
    Kremer V; Oppelaar JJ; Gimbel T; Koziarek S; Ganzevoort W; van Pampus MG; van den Born BJ; Vogt L; de Groot C; Boon RA
    Reprod Sci; 2023 Feb; 30(2):678-689. PubMed ID: 35927413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo Frameshift Variants in the Neuronal Splicing Factor NOVA2 Result in a Common C-Terminal Extension and Cause a Severe Form of Neurodevelopmental Disorder.
    Mattioli F; Hayot G; Drouot N; Isidor B; Courraud J; Hinckelmann MV; Mau-Them FT; Sellier C; Goldman A; Telegrafi A; Boughton A; Gamble C; Moutton S; Quartier A; Jean N; Van Ness P; Grotto S; Nambot S; Douglas G; Si YC; Chelly J; Shad Z; Kaplan E; Dineen R; Golzio C; Charlet-Berguerand N; Mandel JL; Piton A
    Am J Hum Genet; 2020 Apr; 106(4):438-452. PubMed ID: 32197073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A.
    Heinzen EL; Yoon W; Tate SK; Sen A; Wood NW; Sisodiya SM; Goldstein DB
    Am J Hum Genet; 2007 May; 80(5):876-83. PubMed ID: 17436242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis.
    Di Matteo A; Belloni E; Pradella D; Cappelletto A; Volf N; Zacchigna S; Ghigna C
    J Exp Clin Cancer Res; 2020 Dec; 39(1):275. PubMed ID: 33287867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Alternative Splicing Regulator Nova2 Constrains Vascular Erk Signaling to Limit Specification of the Lymphatic Lineage.
    Baek S; Oh TG; Secker G; Sutton DL; Okuda KS; Paterson S; Bower NI; Toubia J; Koltowska K; Capon SJ; Baillie GJ; Simons C; Muscat GEO; Lagendijk AK; Smith KA; Harvey NL; Hogan BM
    Dev Cell; 2019 Apr; 49(2):279-292.e5. PubMed ID: 31014480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential NOVA2-Mediated Splicing in Excitatory and Inhibitory Neurons Regulates Cortical Development and Cerebellar Function.
    Saito Y; Yuan Y; Zucker-Scharff I; Fak JJ; Jereb S; Tajima Y; Licatalosi DD; Darnell RB
    Neuron; 2019 Feb; 101(4):707-720.e5. PubMed ID: 30638744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ-U2AF1 promotes human glioma via derepressing neuro-oncological ventral antigen 2 by sponging hsa-miR-7-5p.
    Li G; Huang M; Cai Y; Yang Y; Sun X; Ke Y
    J Cell Physiol; 2019 Jun; 234(6):9144-9155. PubMed ID: 30341906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo truncating NOVA2 variants affect alternative splicing and lead to heterogeneous neurodevelopmental phenotypes.
    Scala M; Drouot N; MacLennan SC; Wessels MW; Krygier M; Pavinato L; Telegrafi A; de Man SA; van Slegtenhorst M; Iacomino M; Madia F; Scudieri P; Uva P; Giacomini T; Nobile G; Mancardi MM; Balagura G; Galloni GB; Verrotti A; Umair M; Khan A; Liebelt J; Schmidts M; Langer T; Brusco A; Lipska-Ziętkiewicz BS; Saris JJ; Charlet-Berguerand N; Zara F; Striano P; Piton A
    Hum Mutat; 2022 Sep; 43(9):1299-1313. PubMed ID: 35607920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of SULT2B1b Promotes Angiogenesis in Human Gastric Cancer.
    Chen W; Zhou H; Ye L; Zhan B
    Cell Physiol Biochem; 2016; 38(3):1040-54. PubMed ID: 26937945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOVA2-mediated RNA regulation is required for axonal pathfinding during development.
    Saito Y; Miranda-Rottmann S; Ruggiu M; Park CY; Fak JJ; Zhong R; Duncan JS; Fabella BA; Junge HJ; Chen Z; Araya R; Fritzsch B; Hudspeth AJ; Darnell RB
    Elife; 2016 May; 5():. PubMed ID: 27223325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0000376, a Novel circRNA, Promotes the Progression of Non-Small Cell Lung Cancer Through Regulating the miR-1182/NOVA2 Network.
    Li C; Liu H; Niu Q; Gao J
    Cancer Manag Res; 2020; 12():7635-7647. PubMed ID: 32922073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ-EIF3I facilitates proliferation, migration, and invasion of lung cancer via regulating the activity of Wnt/β-catenin pathway through the miR-1253/NOVA2 axis.
    Chen T; Feng G; Xing Z; Gao X
    Thorac Cancer; 2022 Nov; 13(22):3133-3144. PubMed ID: 36193788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.